Clinical Trial Patient Assistance Fund
Funding for the Clinical Trials Patient Assistance Fund has ended. Please contact the Epilepsy & Seizures Helpline at 1-800-332-1000 for other assistance.
The Epilepsy Foundation has developed this program to provide financial assistance to individuals with limited financial resources who have been accepted for enrollment in any IRB-approved clinical trial of an epilepsy therapy and who have signed an informed consent form for the trial. Funding will be made available to help cover out-of-pocket costs associated with participation in these clinical trials. Eligible expenses for reimbursement will include travel expenses to the study site and co-payments, deductibles, and co-insurance required by the patient's health plan.
- Applicants must complete a request for financial assistance application that includes information about the applicant's financial resources available to support clinical trial participation.
- The principal investigator of the applicable clinical trial must sign the application in order to verify that the patient has been accepted into the clinical trial and has given informed consent in accordance with the approved study protocol.
- The Epilepsy Foundation will evaluate the applicant's financial need in accordance with EF guidelines. Generally, eligible individuals will have net income that does not exceed 300% of the federal poverty level. Unusual circumstances may be considered in determining eligibility.
- Generally, the fund will assist the patient with his or her own participation-related expenses only.
- Original receipts (e.g., Explanation of Benefits from health plan; travel expense receipts) are required for reimbursement of expenses.
- The maximum amount that will be awarded per individual will be $3,000 per two-year period.
- Reimbursement will be provided only for the patient's out-of-pocket costs that are not covered by his or her health insurance, Medicare, Medicaid, other federal or state assistance program, or the study sponsor as detailed in the clinical trial's informed consent form. These expenses are anticipated to include co-payments, deductibles, co-insurance, and travel expenses.
- Funds will be awarded to eligible individuals on a first come, first-served basis to the extent that funding is available. Donors to the Patient Assistance Fund or persons related to donors will not receive preferential treatment.
- After an applicant has been notified of his or her acceptance for financial assistance, eligible expenses may be submitted for reimbursement by completing a "Request for Reimbursement of Expenses" form and sending the form along with original receipts to the address below. It is not necessary to complete a new application each time that reimbursement is requested within the two-year award period.
- The following travel expenses will be eligible for reimbursement:
- Air, rail, or bus fare or mileage; lodging; parking and tolls; up to $30 per day for reasonable meal expenses.
- Reimbursement requests must include original receipts, except for mileage, which may be included at $0.40 per mile. Requests for reimbursement must be submitted within 30 calendar days after the last day of travel.
- Send applications and requests for reimbursement to:
Attn: Patient Assistance Fund
8301 Professional Place-West, Suite 230
Landover, MD 20785-2353
(301) 731-3868 (fax)
For additional information about this program, please call (800) 332-1000 or e-mail us.
Download the application:
Epilepsy centers provide you with a team of specialists to help you diagnose your epilepsy and explore treatment options.
Find in-depth information on anti-seizure medications so you know what to ask your doctor.
Epilepsy and Seizures 24/7 Helpline
Call our Epilepsy and Seizures 24/7 Helpline and talk with an epilepsy information specialist or submit a question online.
Tools & Forms
Download our seizure tracking app, print out seizure action plans, or explore other educational materials.